Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-5-27
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0016-5085
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
102
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1822-3
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1345326-Cytochrome P-450 CYP1A2,
pubmed-meshheading:1345326-Cytochrome P-450 Enzyme System,
pubmed-meshheading:1345326-Enzyme Induction,
pubmed-meshheading:1345326-Humans,
pubmed-meshheading:1345326-Liver,
pubmed-meshheading:1345326-Omeprazole,
pubmed-meshheading:1345326-Oxidoreductases
|
pubmed:year |
1992
|
pubmed:articleTitle |
P450IA2 and omeprazole.
|
pubmed:publicationType |
Letter,
Comment
|